Roche and Genentech speak candidly about their fusionBioBusiness 2012, London

International senior biopharma professionals gather in London to deconstruct deal trends and get the low-down and insider knowledge of successful partnering deals at this leading European bio-partnering eventIn light of shrinking product pipelines, decreasing product density and an overall scarcity of financing for early stage innovation, biopharma leaders need to nail the right strategy that will be conducive to successful, long-term innovation and new product creation. For the first time ever Roche and Genentech speak candidly and off the record of what it took to bring to completion